P&R Bidco

Active

Private limited companyfounded 2022active for 4 yearsWetenschapspark 5, 3590 Diepenbeek, BelgiumKBO/BCE: BE 0784.660.219

From the official registers: KBO 4 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

P&R Bidco has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €12.3m and a net result of €4.4m. Equity has been growing by about 6% per year since 2022. Its solvency ranks better than 95% of 9,829 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow Report Compare

P&R BidcoActiveChecked score 94/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 08-04-2022 Normal situation
Legal form: Private limited company
Registered office: Wetenschapspark 5, 3590 Diepenbeek
Activity: Wholesale of pharmaceutical and medical goods NACE 46460
Establishment unit: 2.333.403.096 3590 Diepenbeek, since 08-04-2022
Financial year end: 31 December
Peppol: Reachable since 17-08-2026

Company details

Board and ownership

Board

ILC Newco IV B.V.Director · since 02-05-2023 · permanent representative Peter Segers

Shareholders

ILC NEWCO IV BVconsolidatesannual accounts 2025

Holdings: Shares in 1 company P&R Medical

Board & ownership

Financial position

94 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.2%

Annual accounts 2025

Gross margin: -€26,167; ▼ 15,586%
Profit: €4.4m
Equity: €12.3m; ▲ 55.4%
Total assets: €12.7m; ▲ 2.9%

Turnover not published (abbreviated format)2025 accounts filed 10 days before the deadline

Filed on 21-07-2026at the National Bank

Financials

Score breakdownraises riskLiquidity: current ratio 0.96, cash €389,192Founded in 2022lowers riskSize: total assets €12.7mFigures for financial year 2025 (filed on 21-07-2026)Show the evidence

Checked score

Score 2025

94 / 100

Excellent

Probability in this band: under 0.55%

Financially stronger than 92% of medium-sized companies in wholesale trade (NACE 46)

Every signal that counts is listed under Signals.

Financial strength · tick: 2024

Strong

Solvency 100+11

equity 96.8% of total assets

Liquidity 54+5

short-term debt 3.2% · cash 3.1%

Profitability 100+65

return on assets 34.5%

Bankruptcy probability within 12 months

0.2% Very low

0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (746 companies, NACE 46, medium-sized)

Last 24 months 11-2024: 1.3%highest value 12-2024: 1.3%● unchanged vs 11-2024highest value 01-2025: 1.2%▼ -0.1 percentage points vs 12-2024 02-2025: 1.2%● unchanged vs 01-2025 03-2025: 1.2%● unchanged vs 02-2025 04-2025: 1.2%● unchanged vs 03-2025 05-2025: 1.2%● unchanged vs 04-2025 06-2025: 1.3%▲ +0.1 percentage points vs 05-2025 07-2025: 1.3%● unchanged vs 06-2025 08-2025: 0.7%▼ -0.6 percentage points vs 07-2025 09-2025: 0.7%● unchanged vs 08-2025 10-2025: 0.7%● unchanged vs 09-2025 11-2025: 0.7%● unchanged vs 10-2025 12-2025: 0.6%▼ -0.1 percentage points vs 11-2025 01-2026: 0.6%● unchanged vs 12-2025 02-2026: 0.6%● unchanged vs 01-2026 03-2026: 0.6%● unchanged vs 02-2026 04-2026: 0.6%● unchanged vs 03-2026 05-2026: 0.6%● unchanged vs 04-2026 06-2026: 0.7%▲ +0.1 percentage points vs 05-2026 07-2026: 0.7%● unchanged vs 06-2026 08-2026: 0.2%▼ -0.5 percentage points vs 07-2026lowest value 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026

Credit of up to €1,150,000 on 30-day terms is acceptable

Liquidity is insufficient, with a current ratio of 0.96 (0.02 in 2024), below 1. Short-term debt is 3.2% and cash 3.1% of total assets. 3.2% of the assets are financed with debt and provisions.

Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, medium-sized). It does better than 93% of them on solvency, 81% on liquidity, 99% on profitability and 94% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises riskneutral

Liquidity: current ratio 0.96, cash €389,192

NBB · annual accounts

Founded in 2022

Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.

KBO

Size: total assets €12.7m

Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.

NBB · annual accounts

Figures for financial year 2025 (filed on 21-07-2026)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-07-2026, 10 days ahead of the deadline.

NBB · 4 filings

Deviation from the deadline

2025

10 days early

2024

29 days early

2023

153 days early

2022

20 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

The company filed its last 4 accounts on average 53 days before the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 7 July (3 of the last 4 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

That holds for every publication since incorporation in 2022.

KBO publications

Key points

Positive: Back in profit in 2025after a loss of €134,187 in 2024 €4.4m View
Positive: Largest company by total assets in Diepenbeek, Wholesale and retail trade sectorin the Checked rankings No. 1 View
Positive: Always filed on timeaccounts within the deadline every year 4 years View

Documents

Key facts about P&R Bidco

What is the company number of P&R Bidco?: The company number of P&R Bidco is 0784.660.219. The VAT number is the same number with BE in front: BE 0784.660.219.
Where is P&R Bidco based?: The registered office is at Wetenschapspark 5, 3590 Diepenbeek.Company details
What does P&R Bidco do?: According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of P&R Bidco?: The legal form of P&R Bidco is Private limited company (BV).
When was P&R Bidco founded?: P&R Bidco was founded on 08-04-2022.
Is P&R Bidco still active?: Yes, P&R Bidco is an active enterprise in the KBO register.
What is the turnover of P&R Bidco?: The annual accounts for financial year 2025 state no turnover. The abbreviated format does not require it.Financials
Is P&R Bidco profitable?: In financial year 2025, P&R Bidco made a profit of €4.4m.
Where can I find the annual accounts of P&R Bidco?: P&R Bidco filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of P&R Bidco due?: P&R Bidco must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Companies linked to P&R Bidco

Subsidiaries and holdings

P&R Medical100%

Comparable companies

These companies have the same main activity as P&R Bidco: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €3.1m and €8.7m, founded between 2017 and 2023.

Company	Total assets	Gross margin
P&R Bidco Diepenbeek	€12.7m	-€0.03m
Swiftpharma Genk	€4.9m	-€0.02m
XEOS MEDICAL Gent	€5.5m	-€1.5m
DD DENTAL Antwerpen	€8.7m	-€0.06m
ERC Pharma Gembloux	€3.6m	-€0.06m
Corpowell Antwerpen	€3.4m	-€0.4m
FIDELMED Gent	€3.1m	-€1.3m